UCLA Researchers Develop Viable Bioink for Polyjet 3D-Printed Pills

Published by , February 7, 2017 12:24 pm

(3DPrintingIndustry)  Researchers at the University of California in Los Angeles (UCLA) have developed a viable bioink for 3D printed pills. The 3D printable bioink from UCLA is made from hyaluronic acid – a key ingredient in skin, connective tissues and the nervous system. As of 2011, Stratasys owns the patents to PolyJet technology which combines inject printing with photocuring to make 3D objects.
Improving the translation between pharmaceutical substances and the PolyJet process could mean that tablets are entirely producible by 3D printing, rather than using prefabricated outer shells. Such a development would establish 3D printing as a viable method for pharmaceutical production.

Tags: , , ,